Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers

Grant

Date/time Interval

  • April 1, 2020 - March 31, 2022
  • Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • HHSN261201500036I
  • Contributor

  • Gregory Kennedy M.D.   Principal Investigator